SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on October 3, 2014, reporting events that occurred on September 30, 2014. The filing addresses significant changes in corporate leadership and governance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive personnel changes and does not contain financial statements or performance data.
Material Changes
- Departure of CEO: Eric K. Olson resigned effective September 30, 2014, from his positions as President, Chief Executive Officer, and member of the Board of Directors. He also resigned from all offices with the subsidiary US Spine, Inc.
- Appointment of CEO: B. Sonny Bal, MD, JD, MBA, was appointed President and Chief Executive Officer effective September 30, 2014. Dr. Bal had previously served as a director since February 2012 and Chairman of the Board since August 2014.
- Committee Resignations: In connection with his new executive role, Dr. Bal resigned from the Audit, Compensation, and Nominating and Governance Committees.
Outlook, Risks, and Management Commentary
The filing includes a press release (Exhibit 99.1) detailing the leadership transition. Dr. Bal is identified as a Professor and Chief of Adult Reconstruction at the University of Missouri, specializing in hip and knee replacement surgery, and holds degrees from Cornell University, Northwestern University, and the University of Missouri. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the leadership change.
Key Facts for Investor Verification
- Verify the effective date of the leadership transition (September 30, 2014).
- Confirm the new CEO's background and qualifications as detailed in the press release.
- Review the full text of the press release filed as Exhibit 99.1 for additional context on the departure and appointment.
- Note that this filing contains no financial performance data; refer to recent 10-Q or 10-K filings for financial metrics.